Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Treatment to Regress to Normoglycemia in Women with a Recent History of GDM — Stella

Home/Pre Diabetes/Treatment to Regress to Normoglycemia in Women with a Recent History of GDM

View on ClinicalTrials.gov

Recruiting

Back to Pre Diabetes trials

Treatment to Regress to Normoglycemia in Women with a Recent History of GDM

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Woman's Hospital, Baton Rouge, Louisiana

Key details

Phase

Post-approval study

Sponsor

Woman's

Collaborators

Novo Nordisk A/S

Enrollment target

~102 participants

Started

January 2022

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 45 Years

Sex

Female only

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.